A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity.
Hagemann CA, Legart C, Møllerhøj MB, Madsen MR, Hansen HH, Kønig MJ, Helgstrand F, Hjørne FP, Toxværd A, Langhoff JL, Kielgast UL, Gluud LL, Ægidius H, Rigbolt KTG, Vilsbøll T, Jelsing J, Knop FK.
Hagemann CA, et al. Among authors: toxvaerd a.
PLoS One. 2022 Oct 19;17(10):e0275901. doi: 10.1371/journal.pone.0275901. eCollection 2022.
PLoS One. 2022.
PMID: 36260611
Free PMC article.